Association of matrix metalloproteinases 3 and 9 single nucleotide polymorphisms with breast cancer risk: A case-control study.
Egyptian
breast cancer
matrix metalloproteinase
risk factor
single nucleotide polymorphisms
Journal
Molecular and clinical oncology
ISSN: 2049-9450
Titre abrégé: Mol Clin Oncol
Pays: England
ID NLM: 101613422
Informations de publication
Date de publication:
Jul 2020
Jul 2020
Historique:
received:
05
05
2019
accepted:
15
01
2020
entrez:
27
5
2020
pubmed:
27
5
2020
medline:
27
5
2020
Statut:
ppublish
Résumé
Two single nucleotide polymorphisms (SNPs) of matrix metalloproteinase (MMPs) 3 and 9 are functionally implicated in the progression of various types of cancer, including breast cancer (BC). However, the roles of these SNPs remain controversial. In addition, they also vary between one population and another. Therefore, the present study aimed to investigate the possible association between MMP3-1171 5A/6A and MMP9-1562 CT SNPs and the risk of BC among Egyptians, and to elucidate the alteration of MMP3 and MMP9 gene expression in patients with BC. The present case-control study enrolled 162 patients with BC and 146 control subjects. Restriction fragment length polymorphism-PCR was performed for analysis of the selected SNPs, gene expression of MMP3 and MMP9 was also assessed in 50 patients and 50 control subjects by reverse transcription-quantitative PCR. The frequencies of 5A/6A genotype and 5A allele of MMP3 were significantly higher in patients with BC compared with in healthy subjects. On the other hand, the distributions of MMP9 genotypes and alleles were not significantly different among patients and healthy subjects. Compared with healthy subjects, the expression levels of the two genes were found to be upregulated in patients with BC. Therefore, the present study indicated that MMP3-1171 5A/6A SNP, not MMP9-1562 C>T SNP may be a risk factor for developing BC among Egyptian females.
Identifiants
pubmed: 32454974
doi: 10.3892/mco.2020.2041
pii: MCO-0-0-2041
pmc: PMC7241239
doi:
Types de publication
Journal Article
Langues
eng
Pagination
54-62Informations de copyright
Copyright © 2020, Spandidos Publications.
Références
Dis Markers. 2010;29(1):37-46
pubmed: 20826916
Int J Cancer. 2009 Sep 15;125(6):1473-8
pubmed: 19507256
Lancet Oncol. 2013 Sep;14(10):e417-24
pubmed: 23993386
Tumour Biol. 2014 Feb;35(2):1351-6
pubmed: 24357512
J Soc Gynecol Investig. 2006 Oct;13(7):523-9
pubmed: 16990034
BMC Cancer. 2014 Aug 23;14:609
pubmed: 25151367
Med Sci Monit. 2015 Apr 19;21:1115-23
pubmed: 25890491
J Cancer Epidemiol. 2014;2014:437971
pubmed: 25328522
Nat Genet. 2013 Apr;45(4):392-8, 398e1-2
pubmed: 23535733
Cancer Epidemiol Biomarkers Prev. 2015 Oct;24(10):1495-506
pubmed: 26359465
Biochim Biophys Acta. 2010 Jan;1803(1):3-19
pubmed: 19631700
Nat Genet. 2013 Apr;45(4):353-61, 361e1-2
pubmed: 23535729
Diagn Pathol. 2014 Jul 04;9:136
pubmed: 24993803
Oncogene. 2000 Feb 21;19(8):1102-13
pubmed: 10713697
Intern Med. 2010;49(10):887-95
pubmed: 20467172
Arterioscler Thromb Vasc Biol. 2001 Nov;21(11):1834-9
pubmed: 11701474
Chin J Cancer Res. 2013 Jun;25(3):322-33
pubmed: 23825909
Biomolecules. 2019 Mar 18;9(3):
pubmed: 30889876
DNA Cell Biol. 2013 May;32(5):274-82
pubmed: 23570558
Circulation. 1999 Apr 13;99(14):1788-94
pubmed: 10199873
Rom J Morphol Embryol. 2010;51(2):215-28
pubmed: 20495735
Oncotarget. 2017 Nov 7;8(66):110635-110649
pubmed: 29299175
Biomarkers. 2011 Nov;16(7):577-86
pubmed: 21958210
Circ Res. 2003 Jun 13;92(11):1254-61
pubmed: 12750310
Oncotarget. 2016 Apr 5;7(14):18531-40
pubmed: 26921265
Sci Rep. 2015 Jun 30;5:11667
pubmed: 26123623
PLoS One. 2014 Jan 29;9(1):e87562
pubmed: 24489939
Asian Pac J Cancer Prev. 2015;16(3):1175-9
pubmed: 25735351
Breast Cancer Res Treat. 2007 May;103(1):61-9
pubmed: 17033924
Asian Pac J Cancer Prev. 2015;16(17):7393-400
pubmed: 26625734
Methods. 2001 Dec;25(4):402-8
pubmed: 11846609
Asian Pac J Cancer Prev. 2013;14(3):1615-21
pubmed: 23679245
Breast Cancer Res Treat. 2006 Jan;95(1):65-72
pubmed: 16267613
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
J Cancer Res Clin Oncol. 2013 Sep;139(9):1433-47
pubmed: 23644699
Clin Cancer Res. 2004 Apr 15;10(8):2594-9
pubmed: 15102660
PLoS One. 2017 Sep 29;12(9):e0184448
pubmed: 28961241
J Cell Biochem. 2015 Apr;116(4):502-13
pubmed: 25213553
PLoS One. 2012;7(2):e31251
pubmed: 22348060